Trident Lifeline [TLL] vs Medplus Health [MEDPLUS] Detailed Stock Comparison
Trident Lifeline
BSE
Loading...
Medplus Health
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Trident Lifeline wins in 11 metrics, Medplus Health wins in 8 metrics, with 0 ties. Trident Lifeline appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Trident Lifeline | Medplus Health | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 27.55 | 72.99 | Trident Lifeline |
| Price-to-Book Ratio | 5.34 | 6.25 | Trident Lifeline |
| Debt-to-Equity Ratio | 77.58 | 64.36 | Medplus Health |
| PEG Ratio | 0.32 | 60.53 | Trident Lifeline |
| EV/EBITDA | 20.90 | 36.99 | Trident Lifeline |
| Profit Margin (TTM) | 13.27% | 2.45% | Trident Lifeline |
| Operating Margin (TTM) | 15.70% | 4.78% | Trident Lifeline |
| EBITDA Margin (TTM) | 15.70% | 4.78% | Trident Lifeline |
| Return on Equity | 16.87% | 9.06% | Trident Lifeline |
| Return on Assets (TTM) | 7.53% | 4.66% | Trident Lifeline |
| Free Cash Flow (TTM) | $-213.41M | $4.81B | Medplus Health |
| 1-Year Return | 2.39% | 35.91% | Medplus Health |
| Price-to-Sales Ratio (TTM) | 3.57 | 1.79 | Medplus Health |
| Enterprise Value | $3.71B | $116.28B | Medplus Health |
| EV/Revenue Ratio | 3.81 | 1.90 | Medplus Health |
| Gross Profit Margin (TTM) | 53.63% | 26.56% | Trident Lifeline |
| Revenue per Share (TTM) | $81 | $513 | Medplus Health |
| Earnings per Share (Diluted) | $10.89 | $12.54 | Medplus Health |
| Beta (Stock Volatility) | -0.15 | 0.68 | Trident Lifeline |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Trident Lifeline vs Medplus Health Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Trident Lifeline | -8.48% | 9.81% | 7.14% | -0.33% | 20.00% | 5.63% |
| Medplus Health | 0.45% | 2.12% | 2.83% | 14.51% | 16.44% | 7.87% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Trident Lifeline | 2.39% | 136.03% | 136.03% | 136.03% | 136.03% | 136.03% |
| Medplus Health | 35.91% | 23.80% | -14.94% | -14.94% | -14.94% | -14.94% |
Performance & Financial Health Analysis: Trident Lifeline vs Medplus Health
| Metric | TLL | MEDPLUS |
|---|---|---|
| Market Information | ||
| Market Cap | ₹3.48B | ₹109.55B |
| Market Cap Category | Small cap | Mid cap |
| 10 Day Avg. Volume | 10,680 | 117,398 |
| 90 Day Avg. Volume | 5,880 | 126,728 |
| Last Close | ₹274.55 | ₹919.40 |
| 52 Week Range | ₹222.00 - ₹339.00 | ₹616.00 - ₹1,045.30 |
| % from 52W High | -19.01% | -12.04% |
| All-Time High | ₹339.00 (Sep 02, 2024) | ₹1,343.00 (Jan 17, 2022) |
| % from All-Time High | -19.01% | -31.54% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.80% | 0.01% |
| Quarterly Earnings Growth | 0.74% | 0.54% |
| Financial Health | ||
| Profit Margin (TTM) | 0.13% | 0.02% |
| Operating Margin (TTM) | 0.16% | 0.05% |
| Return on Equity (TTM) | 0.17% | 0.09% |
| Debt to Equity (MRQ) | 77.58 | 64.36 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹56.20 | ₹146.47 |
| Cash per Share (MRQ) | ₹2.35 | ₹30.90 |
| Operating Cash Flow (TTM) | ₹-171,590,000 | ₹5.40B |
| Levered Free Cash Flow (TTM) | ₹117.48M | ₹3.62B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Trident Lifeline vs Medplus Health
| Metric | TLL | MEDPLUS |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 27.55 | 72.99 |
| Forward P/E | N/A | 60.53 |
| PEG Ratio | 0.32 | 60.53 |
| Price to Sales (TTM) | 3.57 | 1.79 |
| Price to Book (MRQ) | 5.34 | 6.25 |
| Market Capitalization | ||
| Market Capitalization | ₹3.48B | ₹109.55B |
| Enterprise Value | ₹3.71B | ₹116.28B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 3.81 | 1.90 |
| Enterprise to EBITDA | 20.90 | 36.99 |
| Risk & Other Metrics | ||
| Beta | -0.15 | 0.68 |
| Book Value per Share (MRQ) | ₹56.20 | ₹146.47 |
Financial Statements Comparison: Trident Lifeline vs Medplus Health
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | TLL | MEDPLUS |
|---|---|---|
| Revenue/Sales | ₹236.05M | ₹15.10B |
| Cost of Goods Sold | ₹109.46M | ₹11.09B |
| Gross Profit | ₹126.60M | ₹4.01B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹37.07M | ₹721.66M |
| EBITDA | ₹65.21M | ₹1.52B |
| Pre-Tax Income | ₹39.34M | ₹611.16M |
| Income Tax | ₹11.50M | ₹97.96M |
| Net Income (Profit) | ₹27.84M | ₹513.20M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | TLL | MEDPLUS |
|---|---|---|
| Cash & Equivalents | ₹24.61M | ₹860.52M |
| Total Current Assets | ₹903.71M | ₹18.44B |
| Total Current Liabilities | ₹535.55M | ₹5.77B |
| Long-Term Debt | ₹322.73M | ₹10.08B |
| Total Shareholders Equity | ₹696.50M | ₹17.40B |
| Retained Earnings | N/A | N/A |
| Property, Plant & Equipment | ₹349.63M | ₹12.49B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | TLL | MEDPLUS |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | TLL | MEDPLUS |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 10,680 | 117,398 |
| Average Daily Volume (90 Day) | 5,880 | 126,728 |
| Shares Outstanding | 11.50M | 119.64M |
| Float Shares | 3.48M | 68.65M |
| % Held by Insiders | 0.77% | 0.42% |
| % Held by Institutions | 0.00% | 0.35% |
Dividend Analysis & Yield Comparison: Trident Lifeline vs Medplus Health
| Metric | TLL | MEDPLUS |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |